US35803L1089 - Common Stock
FREQUENCY THERAPEUTICS INC
NASDAQ:FREQ (11/3/2023, 8:00:00 PM)
0.2996
+0.02 (+5.94%)
Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person’s innate regenerative potential to restore function. The company is headquartered in Lexington, Massachusetts and currently employs 48 full-time employees. The company went IPO on 2019-10-03. The Company, using its progenitor cell activation (PCA) platform, is developing its lead product candidate, FX-322, for the treatment of sensorineural hearing loss (SNHL). FX-322 is designed to treat the underlying cause of SNHL by regenerating hair cells through activation of progenitor cells already present in the cochlea. The firm is also conducting Phase IIb study for the product FX-322. The Company’s SNHL investigational therapeutic program, FX-345, is designed to achieve broader exposure through the cochlea. The Company’s progenitor cell activation (PCA) uses small molecules to activate progenitor cells within the body to create functional tissue.
FREQUENCY THERAPEUTICS INC
75 Hayden Avenue, Suite 300
Lexington MASSACHUSETTS 01801
P: 17813154600.0
CEO: David L. Lucchino
Employees: 48
Website: https://www.frequencytx.com/
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
It's time for a look at the biggest pre-market stock movers as we check out the latest news worth reading on Tuesday morning!
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Here you can normally see the latest stock twits on FREQ, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: